Source:http://linkedlifedata.com/resource/pubmed/id/19655811
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
38
|
pubmed:dateCreated |
2009-9-22
|
pubmed:databankReference | |
pubmed:abstractText |
Bacterial type I signal peptidase (SPase I), an essential membrane-bound endopeptidase with a unique Ser/Lys dyad mechanism, is being investigated as a potential novel antibiotic target. We present here binding and inhibition assays along with crystallographic data that shows that the lipohexapeptide-based natural product arylomycin A2 and the morpholino-beta-sultam derivative (BAL0019193) inhibit SPase I by binding to non-overlapping subsites near the catalytic center. The 2.0 A resolution crystal structure of the soluble catalytic domain of Escherichia coli SPase I (SPase I Delta2-75) in ternary complex with arylomycin A2 and BAL0019193 reveals the position of BAL0019193 adjacent to arylomycin A2 within the SPase I binding site. BAL0019193 binds in a noncovalent manner in close proximity to SPase I residues Ser88, Ser90, Lys145, Asn277, Ala279, and Glu307, as well as atom O45 of arylomycin A2. The binding mode of arylomycin A2 in this 2.0 A resolution ternary complex is compared to that seen in the previous 2.5 A resolution arylomycin A2-SPase cocrystal structure. This work contributes to our understanding of SPase I inhibitor/substrate recognition and should prove helpful in the further development of novel antibiotics based on the inhibition of SPase I.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Escherichia coli Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Macromolecular Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Proteinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/arylomycin A2,
http://linkedlifedata.com/resource/pubmed/chemical/type I signal peptidase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1520-4995
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
29
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8976-84
|
pubmed:meshHeading |
pubmed-meshheading:19655811-Catalytic Domain,
pubmed-meshheading:19655811-Crystallography, X-Ray,
pubmed-meshheading:19655811-Escherichia coli Proteins,
pubmed-meshheading:19655811-Kinetics,
pubmed-meshheading:19655811-Macromolecular Substances,
pubmed-meshheading:19655811-Membrane Proteins,
pubmed-meshheading:19655811-Models, Molecular,
pubmed-meshheading:19655811-Molecular Structure,
pubmed-meshheading:19655811-Oligopeptides,
pubmed-meshheading:19655811-Peptide Fragments,
pubmed-meshheading:19655811-Serine Endopeptidases,
pubmed-meshheading:19655811-Serine Proteinase Inhibitors,
pubmed-meshheading:19655811-Static Electricity,
pubmed-meshheading:19655811-Sulfonamides
|
pubmed:year |
2009
|
pubmed:articleTitle |
Crystallographic analysis of bacterial signal peptidase in ternary complex with arylomycin A2 and a beta-sultam inhibitor.
|
pubmed:affiliation |
Department of Molecular Biology and Biochemistry, Simon Fraser University, South Science Building 8888 University Drive, Burnaby, British Columbia, V5A 1S6 Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|